US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Ongoing

0.9% Sodium Chloride Injection

Reason Lack of Assurance of Sterility

Fresenius Kabi USA, LLC D-0425-2026
Class II · Moderate risk Ongoing

Icosapent Ethyl Capsules

Reason Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.

Zydus Pharmaceuticals (USA) Inc D-0400-2026
Class II · Moderate risk Ongoing

SLMD Benzoyl Peroxide Acne Lotion

Reason Chemical contamination: Presence of benzene

Owen Biosciences Inc. D-0455-2026
Class II · Moderate risk Ongoing

SLMD BP Acne Spot Treatment

Reason Chemical contamination: Presence of benzene

Owen Biosciences Inc. D-0454-2026
Class II · Moderate risk Ongoing

HydroPeptide CLEAR ALLIANCE SERUM

Reason Chemical contamination: Presence of benzene

Owen Biosciences Inc. D-0453-2026
Class II · Moderate risk Ongoing

FHF Farmhouse Fresh

Reason Chemical contamination: Presence of benzene

Owen Biosciences Inc. D-0452-2026
Class II · Moderate risk Ongoing

Sterile Eye Drops Soothing Tears

Reason Lack of Assurance of Sterility

K.C. Pharmaceuticals, Inc NDC 0536-1219-94 D-0415-2026
Class II · Moderate risk Ongoing

Sterile EYE DROPS REDNESS LUBRICANT

Reason Lack of Assurance of Sterility

K.C. Pharmaceuticals, Inc NDC 46122-606-05 D-0414-2026
Class II · Moderate risk Ongoing

Sterile Eye Drops ORIGINAL FORMULA

Reason Lack of Assurance of Sterility

K.C. Pharmaceuticals, Inc NDC 50804-141-01 D-0413-2026
Class II · Moderate risk Ongoing

Ultra Lubricating Eye Drops

Reason Lack of Assurance of Sterility

K.C. Pharmaceuticals, Inc NDC 70000-0457-1 D-0412-2026
Class II · Moderate risk Ongoing

Dry Eye Relief Eye Drops

Reason Lack of Assurance of Sterility

K.C. Pharmaceuticals, Inc NDC 57896-181-05 D-0411-2026
Class II · Moderate risk Ongoing

EYE DROPS Advanced Relief

Reason Lack of Assurance of Sterility

K.C. Pharmaceuticals, Inc NDC 83324-191-14 D-0410-2026
Class II · Moderate risk Ongoing

Sterile EYE DROPS AC

Reason Lack of Assurance of Sterility

K.C. Pharmaceuticals, Inc NDC 83324-190-14 D-0409-2026
Class II · Moderate risk Ongoing

Product label: Temozolomide Capsules

Reason Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing

Rising Pharma Holding, Inc. NDC 16571-816-51 D-0384-2026
Class II · Moderate risk Ongoing

Children's Ibuprofen Oral Suspension

Reason Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.

Strides Pharma INC NDC 51672-5321-8 D-0390-2026
Class II · Moderate risk Ongoing

Tirzepatide Inj

Reason Lack of Assurance of Sterility

New Life Pharma LLC NDC 84223-002-04 D-0395-2026
Class II · Moderate risk Ongoing

Tirzepatide Inj

Reason Lack of Assurance of Sterility

New Life Pharma LLC NDC 84223-002-03 D-0394-2026
Class II · Moderate risk Ongoing

Semaglutide Inj.

Reason Lack of Assurance of Sterility

New Life Pharma LLC NDC 84223-001-06 D-0393-2026
Class II · Moderate risk Ongoing

Semaglutide Inj

Reason Lack of Assurance of Sterility

New Life Pharma LLC NDC 84223-001-07 D-0392-2026
Class II · Moderate risk Ongoing

Amnesteem

Reason Failed Dissolution Specifications

Mylan Pharmaceuticals INC NDC 0378-6614-93 D-0399-2026